Clinical Trials · NCT04962503
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 6
- Start date
- Jun 2021
- Locations
- 1 site, Australia
- Primary endpoint
- Changes in Volume of Infarct